Reuters logo
BRIEF-AnaptysBio reports positive ANB019 top-line phase 1 clinical trial results
November 6, 2017 / 9:56 PM / 16 days ago

BRIEF-AnaptysBio reports positive ANB019 top-line phase 1 clinical trial results

Nov 6 (Reuters) - Anaptysbio Inc

* Anaptysbio reports positive anb019 top-line phase 1 clinical trial results

* Top-line data demonstrated favorable safety, pharmacokinetics and pharmacodynamic properties in study​

* ANB019 was well-tolerated by all subjects and no dose-limiting toxicities were observed to date in study​

* Plans to initiate phase 2 clinical trials of ANB019 in generalized pustular psoriasis, palmo-plantar pustular psoriasis patients in 2018​ Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below